OCUP - Ocuphire Pharma GAAP EPS of $0.25 revenue of $11.94M
2023-11-13 14:30:41 ET
More on Ocuphire Pharma
- Viatris and Ocuphire Pharma announce FDA approval for eye drop formulation RYZUMVl
- Seeking Alpha’s Quant Rating on Ocuphire Pharma
- Historical earnings data for Ocuphire Pharma
- Financial information for Ocuphire Pharma
For further details see:
Ocuphire Pharma GAAP EPS of $0.25, revenue of $11.94M